南方医药保健灵活配置混合C(014933)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
443,320,263.69 |
-379,030,298.57 |
-281,887,448.28 |
-278,938,714.97 |
| 利息合计 |
361,008.98 |
2,032,589.70 |
1,245,979.86 |
776,968.22 |
| 其中：存款利息收入 |
106,946.68 |
523,523.38 |
249,361.82 |
675,928.20 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
254,062.30 |
1,509,066.32 |
996,618.04 |
101,040.02 |
| 投资收益合计 |
262,596,830.30 |
-287,718,185.30 |
-228,837,730.29 |
-428,889,141.29 |
| 其中：股票投资收益 |
252,135,024.06 |
-323,240,295.67 |
-253,669,554.40 |
-458,013,767.01 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
502,534.11 |
3,403,850.30 |
1,612,306.56 |
3,026,133.04 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
9,959,272.13 |
32,118,260.07 |
23,219,517.55 |
26,098,492.68 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
179,860,569.60 |
-94,248,239.31 |
-54,536,680.60 |
148,149,302.37 |
| 其他收入 |
501,854.81 |
903,536.34 |
240,982.75 |
1,024,155.73 |
| 费用 |
15,842,520.44 |
39,411,713.28 |
19,028,646.42 |
46,424,335.92 |
| 管理人报酬 |
13,415,417.98 |
33,462,339.93 |
16,148,961.07 |
39,434,275.74 |
| 基金托管费 |
2,235,903.02 |
5,577,056.67 |
2,691,493.59 |
6,572,379.30 |
| 销售服务费 |
55,163.38 |
115,618.53 |
58,129.28 |
163,288.78 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
136,036.06 |
256,697.76 |
130,062.09 |
254,390.69 |
| 利润总额 |
427,477,743.25 |
-418,442,011.85 |
-300,916,094.70 |
-325,363,050.89 |
微信公众号
证券之星APP
基本资料
